fda bpc-157 category 2 bulk drug substances list An advisory committee to voted 8-6 with one abstention on Thursday to recommend that two peptides – to treat ulcerative colitis and KPV for wound treatment and inflammatory conditions – FDA Peptide Compounding Vote 2026:

Here are the problems people actually encounter and how to solve them

A peptide may appear promising in early studies, but that does not automatically translate into predictable real-world results for patients with insomnia, anxiety, trauma-related sleep disturbance, sleep apnea, medication-related sleep problems, or other conditions

Atrophic gastritis , often associated with Helicobacter pylori infection or autoimmunity, reduces gastric acid secretion necessary for releasing food-bound B12

However, these patients had multiple risk factors for b12 deficiency beyond semaglutide use, including previous gastric surgery that permanently alters stomach anatomy and reduces intrinsic factor production